Charts

Virax Biolabs ("Virax" or the "Company") (NASDAQ: VRAX), an innovative biotechnology company focused on the detection of immune responses and diagnosis of viral diseases, today announced that Chief Operating Officer, Dr Nigel McCracken is presenting at H.C. Wainwright's 26th Annual Global Investment Conference, held in New York, NY and that the pre-recorded and on-demand presentation is now available.

Each trading day features hundreds of headlines and press releases on Benzinga Pro, a source for traders to see the latest news on the ...

Virax Biolabs Group Limited ("Virax" or the "Company") (Nasdaq: VRAX), an innovative biotechnology company focused on the detection of immune responses and diagnosis of viral diseases, announced today it will be hosting a booth at the 7th European Congress of Immunology (ECI), which is taking place from September 1 - 4, 2024, in Dublin, Ireland.

U.S. stocks traded lower midway through trading, with the Nasdaq Composite falling over 1% on Wednesday. The Dow traded down 0.42% to ...

Virax Biolabs Group Limited (NASDAQ:VRAX) stock is trading higher on Wednesday after the company announced it entered into a ...

U.S. stocks traded mixed this morning, with the Dow Jones index gaining over 50 points on Wednesday. The Dow traded up 0.17% to ...

Virax Biolabs Group Limited (NASDAQ: VRAX) ("Virax" or the "Company"), an innovative biotechnology company focused on the detection of immune responses and diagnosis of viral diseases, today announced that it has entered into a distribution agreement with a supplier of (RT) PCR Mpox virus detection kits to commercialize them in 13 European countries as well as members of the Gulf Cooperation Council ("GCC") including Bahrain, Kuwait, Oman, Qatar, Saudi Arabia, and the United Arab Emirates.

Wednesday, Virax Biolabs Group Limited (NASDAQ:VRAX) entered into a distribution agreement with a supplier of (RT) PCR Mpox virus ...

Virax Biolabs Group Limited ("Virax" or the "Company") (Nasdaq: VRAX), an innovative biotechnology company focused on the detection of immune responses and diagnosis of viral diseases, today announced the closing of its previously announced registered direct offering for the purchase and sale of an aggregate of 1,108,892 of its ordinary shares at a purchase price of $4.50 per share.

Virax Biolabs Group Limited (NASDAQ:VRAX) shares are trading lower Thursday after the company announced a $5 million registered direct ...

Shares of Wolfspeed, Inc. (NYSE:WOLF) shares gained 8.2% to $14.62 in pre-market trading after the company reported its fourth-quarter ...

Virax Biolabs Group Limited ("Virax" or the "Company") (Nasdaq: VRAX), an innovative biotechnology company focused on the detection of immune responses and diagnosis of viral diseases, announced today that it has entered into a definitive agreement for the issuance and sale of an aggregate of 1,108,892 of its ordinary shares at a purchase price of $4.50 per share in a registered direct offering. The closing of the offering is expected to occur on or about August 23, 2024, subject to the satisfac

Cosmos Health Inc. (NASDAQ:COSM) stock is trading higher on Wednesday after the company said it continues to hold the right to ...

CHICAGO, IL / ACCESSWIRE / August 21, 2024 / Cosmos Health Inc. ("Cosmos Health" or the "Company'') (NASDAQ:COSM), a diversified, vertically integrated global healthcare group engaged in innovative R&D, owner of proprietary pharmaceutical and nutraceutical brands, manufacturer and distributor of healthcare products, and operator of a telehealth platform, announced today, pursuant to its agreement with Virax Biolabs (NASDAQ: VRAX), that it continues to hold the rights to distribute mpox virus real-time PCR detection kits, with exclusive distribution rights in Greece and Cyprus, and non-exclusive distribution rights across Europe.

Virax Biolabs Group's (NYSE:VRAX) short percent of float has fallen 54.22% since its last report. The company recently reported that it ...

Virax Biolabs Group, GeoVax Labs, Applied DNA Sciences and Emergent BioSolutions have been highlighted in this Investment Ideas article.

U.S. stocks traded higher toward the end of trading, with the Nasdaq Composite gaining around 150 points on Monday. The Dow traded up ...

Shares of Nikola Corporation (NASDAQ:NKLA) fell sharply in Monday's session after the company announced it entered into a securities ...

U.S. stocks traded higher midway through trading, with the Dow Jones index gaining more than 150 points on Monday. The Dow traded up ...

Virax Biolabs Group Limited (NASDAQ:VRAX) shares are racing higher Monday as shares of mpox-related stocks climb after the World Health ...

U.S. stocks traded mostly higher this morning, with the Dow Jones index gaining more than 100 points on Monday. The Dow traded up ...

Shares of Xperi Inc. (NYSE:XPER) rose sharply in today's pre-market trading after the company announced that it entered into an ...

Gainers Viracta Therapeutics (NASDAQ:VIRX) stock increased by 16.8% to $0.68 during Tuesday's pre-market session. The company's market ...

Shares of Skye Bioscience, Inc. (NASDAQ:SKYE) fell sharply during Monday's session after the company announced its SBI-100 Ophthalmic ...

Shares of KKR & Co. Inc. (NYSE:KKR) rose sharply in today's pre-market trading after it was announced the company will join the ...

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Virax Biolabs stock is down on Friday as shares of VRAX come off of a massive rally yesterday that didn't come with any news. The post Why Is Virax Biolabs (VRAX) Stock Down 15% Today? appeared first on InvestorPlace. More From InvestorPlace The #1 AI Investment Might Be This Company You’ve Never Heard Of Musk’s “Project Omega” May Be Set to Mint New Millionaires. Here’s How to Get In. Legendary Investor Predicts: “Forget A.I. THIS Technology Is the Future”

Gainers Venus Concept (NASDAQ:VERO) shares increased by 135.2% to $1.38 during Friday's pre-market session. The market value of their ...

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Pre-market stock movers are worth checking out on Friday as we dig into all of the biggest news affecting shares this morning! The post Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday appeared first on InvestorPlace. More From InvestorPlace The #1 AI Investment Might Be This Company You’ve Never Heard Of Musk’s “Project Omega” May Be Set to Mint New Millionaires. Here’s How to Get In. Legendary Investor Predicts: “Forget A.I. THIS Technology Is the Future”

Shares of Braze, Inc. (NASDAQ:BRZE) rose sharply in today's pre-market trading following better-than-expected first-quarter ...

Shares of G-III Apparel Group, Ltd. (NASDAQ:GIII) fell sharply during Thursday's session after the company reported worse-than-expected ...

Gainers Virax Biolabs Group (NASDAQ:VRAX) shares rose 88.8% to $2.02 during Thursday's regular session. The company's market cap stands ...

U.S. stocks traded mostly higher this morning, with the Dow Jones gaining around 100 points on Thursday. Following the market opening ...

Shares of Smartsheet Inc. (NYSE:SMAR) rose sharply in today's pre-market trading after the company reported better-than-expected ...

Gainers Aethlon Medical (NASDAQ:AEMD) shares moved upwards by 124.3% to $0.98 during Thursday's pre-market session. The company's ...

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Virax Biolabs stock is up on Thursday alongside heavy pre-market trading of VRAX shares despite a lack of news from the company. The post Why Is Virax Biolabs (VRAX) Stock Up 115% Today? appeared first on InvestorPlace. More From InvestorPlace The #1 AI Investment Might Be This Company You’ve Never Heard Of Musk’s “Project Omega” May Be Set to Mint New Millionaires. Here’s How to Get In. Legendary Investor Predicts: “Forget A.I. THIS Technology Is the Future”

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Pre-market stock movers are worth checking out on Thursday morning as we dive into all of the hottest news affecting shares this morning! The post Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday appeared first on InvestorPlace. More From InvestorPlace The #1 AI Investment Might Be This Company You’ve Never Heard Of Musk’s “Project Omega” May Be Set to Mint New Millionaires. Here’s How to Get In. Legendary Investor Predicts: “Forget A.I. THIS Technology Is the Future”

Virax Biolabs Group Limited (NASDAQ: VRAX) ("Virax" or the "Company"), an innovative biotechnology company focused on the detection of immune responses and diagnosis of viral diseases, announced today the launch of ImmuneSelect ("ImmuneSelect") within the ViraxImmune™ T-Cell diagnostic platform for research-use-only ("RUO"), at the European Society of Clinical Microbiology and Infectious Diseases Global 2024 (ESCMID) Congress, which is taking place from April 27th to April 30th, 2024, in Barcelo

Thursday,Virax Biolabs Group Limited(NASDAQ:VRAX) announced it is launching ‘ImmuneSelect' within the ViraxImmune ...

Gainers Trevena (NASDAQ:TRVN) shares increased by 27.0% to $0.51 during Wednesday's after-market session. The company's market cap ...

Virax Biolabs Group Limited (NASDAQ: VRAX) ("Virax" or the "Company"), an innovative biotechnology company focused on the detection of immune responses and diagnosis of viral diseases, announced today that it will be hosting a booth at the European Society of Clinical Microbiology and Infectious Diseases Global 2024 (ESCMID) on April 27-30, 2024, in Barcelona, Spain.

Virax Biolabs Group Limited (NASDAQ: VRAX) ("Virax" or the "Company"), an innovative biotechnology company focused on the detection of immune responses and diagnosis of viral diseases, announced that it received a notice from The Nasdaq Stock Market LLC ("Nasdaq") dated March 13, 2024, notifying the Company that it is not in compliance with the minimum bid price requirement as set forth under NASDAQ Listing Rule 5550(a)(2)(the "Minimum Bid Price Rule") for continued listing on the NASDAQ.

Gainers Ocean Biomedical (NASDAQ:OCEA) stock rose 37.6% to $2.16 during Friday's after-market session. The company's market cap stands ...

Gainers Telesis Bio (NASDAQ:TBIO) shares rose 114.3% to $0.97 during Thursday's after-market session. The market value of their ...

Shares of LQR House Inc. (NASDAQ: LQR) rose sharply in pre-market trading. Borg's investor group has acquired a 20% stake in LQR ...

Shares of Trinity Place Holdings Inc. (NYSE: TPHS) rose sharply in pre-market trading. The company reported in 8K Filing, mortgage ...

InvestorPlace - Stock Market News, Stock Advice & Trading Tips It's time to dive into the biggest pre-market stock movers with all of the latest coverage worth reading about on Wednesday morning! The post Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday appeared first on InvestorPlace. More From InvestorPlace ChatGPT IPO Could Shock the World, Make This Move Before the Announcement Musk’s “Project Omega” May Be Set to Mint New Millionaires. Here’s How to Get In. The Rich Use This Income Secret (NOT Dividends) Far More Than Regular Investors

Shares of Bridgeline Digital, Inc. (NASDAQ: BLIN) fell sharply in pre-market following the release of fourth-quarter ...

Shares of Reneo Pharmaceuticals, Inc. (NASDAQ: RPHM) shares rose sharply during Wednesday’s session after Concentra sent an ...

Virax Biolabs Group Limited (NASDAQ: VRAX) ("Virax" or the "Company"), an innovative biotechnology company focused on the detection of immune responses and diagnosis of viral diseases, today announced a strategic collaboration with the University of Manchester and the Northern Care Alliance Foundation Trust, who have a track record in working together to deliver translational immunology research for respiratory viral infections. This collaboration aims to apply the ViraxImmune IVD platform to br

Virax Biolabs Group Limited ("Virax" or the "Company") (Nasdaq: VRAX), today announced that Mr. James Foster, Chief Executive Officer of Virax, has issued a letter to shareholders that provides an update on recent events and an outlook for 2024.

Virax Biolabs Group Limited (NASDAQ: VRAX) ("Virax" or the "Company"), an innovative diagnostics company focused on the detection of immune responses and diagnosis of viral diseases, today announced that the annual general meetings of the shareholders held on Wednesday, December 6, 2023, at BioCity Glasgow, Bo'Ness Road, Newhouse, Lanarkshire, ML1 5UH, approved the proposed 1-for-10 share consolidation of its ordinary shares of US$0.0001 par value each (the "Share Consolidation").

By Thomas Kerr, CFA NASDAQ:VRAX READ THE FULL VRAX RESEARCH REPORT On September 12, 2023, Virax Biolabs (NASDAQ:VRAX) announced the launch of an early access program for research-use-only ("RUO") of its proprietary SARS-Cov-2 ViraxImmune T-cell-based test. The early access program offers select research groups an opportunity to be at the forefront of immune assessment advancements. The RUO form

Gainers NovaBay Pharmaceuticals (AMEX:NBY) stock rose 109.7% to $1.3 during Monday's pre-market session. The company's market cap ...

InvestorPlace - Stock Market News, Stock Advice & Trading Tips We're starting off the workweek right with a breakdown of the biggest pre-market stock movers worth watching on Monday morning! The post Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday appeared first on InvestorPlace. More From InvestorPlace ChatGPT IPO Could Shock the World, Make This Move Before the Announcement Musk’s “Project Omega” May Be Set to Mint New Millionaires. Here’s How to Get In. The Rich Use This Income Secret (NOT Dividends) Far More Than Regular Investors

Friday's session saw 225 companies set new 52-week lows. Significant Points From Today's 52-Week ...

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Ballard Power Systems (BLDP) stock is getting a boost on Thursday after announcing a partnership with Ford (F) for hydrogen fuel cell tech. The post Why Is Ballard Power (BLDP) Stock Up 7% Today? appeared first on InvestorPlace. More From InvestorPlace Buy This $5 Stock BEFORE This Apple Project Goes Live Wall Street Titan: Here’s My #1 Stock for 2023 The $1 Investment You MUST Take Advantage of Right Now It doesn’t matter if you have $500 or $5 million. Do this now.

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Sunrun (RUN) stock is taking off on Thursday alongside earnings and a new price prediction from Janney Montgomery Scott analyst Thomas Meric. The post RUN Stock Price Prediction: Can Sunrun Really Rally 80% From Here? appeared first on InvestorPlace. More From InvestorPlace Buy This $5 Stock BEFORE This Apple Project Goes Live Wall Street Titan: Here’s My #1 Stock for 2023 The $1 Investment You MUST Take Advantage of Right Now It doesn’t matter if you have $500 or $5 million. Do this now.